Authors:
Agelaki, S
Kakolyris, S
Palamidas, P
Kouroussis, C
Mavroudis, D
Kalbakis, K
Georgoulias, V
Raptis, A
Citation: S. Agelaki et al., A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer, LUNG CANC, 34(1), 2001, pp. 133-139
Citation: A. Raptis, Local similarity transformations for the boundary layer flow through a homogeneous porous medium by the presence of heat transfer, INT COMM HE, 27(5), 2000, pp. 739-743
Authors:
Clave, E
Molldrem, J
Hensel, N
Raptis, A
Barrett, AJ
Citation: E. Clave et al., Donor-recipient polymorphism of the proteinase 3 gene: A potential target for T-cell alloresponses to myeloid leukemia, J IMMUNOTH, 22(1), 1999, pp. 1-6
Authors:
Raptis, A
Mavroudis, D
Suffredini, AF
Molldrem, J
Van Rhee, F
Childs, R
Phang, S
Barrett, AJ
Citation: A. Raptis et al., High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients, BONE MAR TR, 24(8), 1999, pp. 879-883
Authors:
Lakhani, A
Raptis, A
Frame, D
Simpson, D
Berkahn, L
Mellon-Reppen, S
Klingemann, H
Citation: A. Lakhani et al., Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis, BONE MAR TR, 24(11), 1999, pp. 1259-1260
Authors:
van Rhee, F
Jiang, YZ
Vigue, F
Kirby, M
Mavroudis, D
Hensel, NF
Agarwala, V
Clave, E
Childs, R
Raptis, A
Sloand, E
Carter, C
Read, EJ
Barrett, J
Citation: F. Van Rhee et al., Human G-CSF-mobilized CD34-positive peripheral blood progenitor cells callstimulate allogeneic T-cell responses: implications for graft rejection inmismatched transplantation, BR J HAEM, 105(4), 1999, pp. 1014-1024